Sonova Holding AG (SWX:SOON)
Switzerland · Delayed Price · Currency is CHF 204.80
+0.60 (0.29%)
Jun 2, 2026, 5:30 PM CET
Revenue
Financials in millions CHF. Fiscal year is April - March.
Millions CHF. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 | Mar '13 Mar 31, 2013 |
Hearing Instruments Business Revenue | 1.86B | 1.82B | ||||||||||||
Hearing Instruments Business Revenue Growth | 2.22% | 7.29% | ||||||||||||
Audiological Care Business Revenue | 1.49B | 1.49B | ||||||||||||
Audiological Care Business Revenue Growth | 0.30% | 5.46% | ||||||||||||
Consumer Hearing Business Revenue | - | 252.50M | ||||||||||||
Consumer Hearing Business Revenue Growth | - | 5.34% | ||||||||||||
Total Hearing Instruments Segment Revenue | 3.35B | 3.31B | ||||||||||||
Total Hearing Instruments Segment Revenue Growth | 1.36% | -1.17% | ||||||||||||
Cochlear Implant Systems Revenue | 179.60M | 214.90M | ||||||||||||
Cochlear Implant Systems Revenue Growth | -16.43% | 15.85% | ||||||||||||
Upgrades and Accessories Revenue | 72.50M | 89.00M | ||||||||||||
Upgrades and Accessories Revenue Growth | -18.54% | -4.71% | ||||||||||||
Total Cochlear Implants Segment Revenue | 252.10M | 303.90M | ||||||||||||
Total Cochlear Implants Segment Revenue Growth | -17.04% | 8.96% | ||||||||||||
Revenue (Other) | - | -252.40M | ||||||||||||
Revenue (Total) | 3.61B | 3.61B | ||||||||||||
Revenue (Total) Growth | -0.19% | -0.39% |
Revenue by Geography
Financials in millions CHF. Fiscal year is April - March.
Millions CHF. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 | Mar '13 Mar 31, 2013 |
Switzerland Revenue | 28.60M | 27.50M | ||||||||||||
Switzerland Revenue Growth | 4.00% | -10.13% | ||||||||||||
EMEA (excl. Switzerland) Revenue | 1.88B | 1.84B | ||||||||||||
EMEA (excl. Switzerland) Revenue Growth | 1.88% | 0.68% | ||||||||||||
USA Revenue | 1.09B | 1.11B | ||||||||||||
USA Revenue Growth | -1.16% | 3.03% | ||||||||||||
Americas (excl. USA) Revenue | 263.90M | 267.00M | ||||||||||||
Americas (excl. USA) Revenue Growth | -1.16% | 0.98% | ||||||||||||
Asia/Pacific Revenue | 344.10M | 371.00M | ||||||||||||
Asia/Pacific Revenue Growth | -7.25% | -13.60% | ||||||||||||
Revenue (Total) | 3.61B | 3.61B | ||||||||||||
Revenue (Total) Growth | -0.19% | -0.39% |
EBITDA
Financials in millions CHF. Fiscal year is April - March.
Millions CHF. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 | Mar '13 Mar 31, 2013 |
Hearing Instruments Segment Operating Profit Before Acquisition-Related Amortization (EBITA) | 758.70M | 740.00M | ||||||||||||
Hearing Instruments Segment Operating Profit Before Acquisition-Related Amortization (EBITA) Growth | 2.53% | 5.46% | ||||||||||||
Cochlear Implants Segment Operating Profit Before Acquisition-Related Amortization (EBITA) | -34.60M | 28.40M | ||||||||||||
Cochlear Implants Segment Operating Profit Before Acquisition-Related Amortization (EBITA) Growth | - | 11.81% | ||||||||||||
Operating Income (Other) | -48.30M | -48.60M | ||||||||||||
Operating Income (Total) | 675.80M | 719.80M | ||||||||||||
Operating Income (Total) Growth | -6.11% | 7.45% |
Key Performance Indicators
Financials in millions CHF. Fiscal year is April - March.
Millions CHF. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 | Mar '13 Mar 31, 2013 |
Hearing Instruments Business Growth in Local Currencies | - | 8.50% | ||||||||||||
Audiological Care Business Growth in Local Currencies | - | 6.40% | ||||||||||||
Consumer Hearing Business Growth in Local Currencies | - | 6.40% | ||||||||||||
Total Hearing Instruments Segment Growth in Local Currencies | 7.50% | 7.50% | ||||||||||||
Cochlear Implant Systems Growth in Local Currencies | - | 16.30% | ||||||||||||
Upgrades and Accessories Growth in Local Currencies | - | -3.90% | ||||||||||||
Total Cochlear Implants Segment Growth in Local Currencies | -11.10% | 9.50% |
Updated Mar 31, 2026. Data Source: Fiscal.ai.